Lung Cancer

Breaking news, expert perspectives, and real-world guidance—tailored for community care.
Power Your Practice with Smarter Oncology Insights

NSCLC

Browse all NSCLC

NSCLC

Ep. 1: Overcoming Infusion Barriers in EGFR-Mutant Non–Small Cell Lung Cancer

Chinmay Jani, MD, Luis Raez, MD, FACP, FCCP, FASCO

NSCLC

Ep. 5: CNS Activity and Sequencing Strategies for Datopotamab Deruxtecan in EGFR-Mutant NSCLC

Aaron Lisberg, MD, Sarah Sunshine, MD, Blanca Ledezma, NP, Rahul Gosain, MD, MBA, Rohit Gosain, MD

NSCLC

Ep. 4: Datopotamab Deruxtecan in EGFR-Mutated NSCLC: Community-Based Monitoring and Toxicity Management

Aaron Lisberg, MD, Sarah Sunshine, MD, Blanca Ledezma, NP, Rahul Gosain, MD, MBA, Rohit Gosain, MD

NSCLC

EP. 3: Monitoring, Dosing, and Rechallenge Strategies With Datopotamab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer

Aaron Lisberg, MD, Sarah Sunshine, MD, Blanca Ledezma, NP, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

Browse all SCLC

SCLC

EP. 6: Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Isabel Preeshagul, DO, MBS, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

EP. 5: Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

EP. 4: Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBS, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

SCLC

Ep. 3: Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MD, Stephen Liu, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD